Literature DB >> 27140989

Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002-12.

Matthew V Ronan1, Shoshana J Herzig2.   

Abstract

Serious infection is a recognized complication of intravenous drug abuse and a major cause of morbidity and mortality among intravenous drug users. Trends in rates of serious infection and the associated costs related to opioid abuse/dependence have not been previously investigated in the context of the US opioid use epidemic. Our study, using a nationally representative sample of US inpatient hospitalizations, showed that hospitalizations related to opioid abuse/dependence both with and without associated serious infection significantly increased from 2002 to 2012, respectively, from 301,707 to 520,275 and from 3,421 to 6,535. Additionally, inpatient charges for both types of hospitalizations almost quadrupled over the same time period, reaching almost $15 billion for hospitalizations related to opioid abuse/dependence and more than $700 million for those related to associated infection in 2012. Medicaid was the most common primary payer for both types of hospitalizations. Our results characterize the financial burden on the health care system related to opioid abuse/dependence and one of the more serious downstream complications of this epidemic: serious infection. These findings have important implications for the hospitals and government agencies that disproportionately shoulder these costs and for clinicians, researchers, and policy makers interested in estimating the potential impact of targeted public health interventions on a national level. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Health Economics; Hospitals; Medicine/Clinical Issues; Mental Health/Substance Abuse; infectious disease

Mesh:

Substances:

Year:  2016        PMID: 27140989      PMCID: PMC5240777          DOI: 10.1377/hlthaff.2015.1424

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  14 in total

1.  A flood of opioids, a rising tide of deaths.

Authors:  Susan Okie
Journal:  N Engl J Med       Date:  2010-11-18       Impact factor: 91.245

2.  Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States.

Authors:  Theodore J Cicero; Matthew S Ellis; Jessie Harney
Journal:  N Engl J Med       Date:  2015-10-29       Impact factor: 91.245

3.  Drug-poisoning deaths involving heroin: United States, 2000-2013.

Authors:  Holly Hedegaard; Li-Hui Chen; Margaret Warner
Journal:  NCHS Data Brief       Date:  2015-03

4.  Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.

Authors:  Sadip Pant; Nileshkumar J Patel; Abhishek Deshmukh; Harsh Golwala; Nilay Patel; Apurva Badheka; Glenn A Hirsch; Jawahar L Mehta
Journal:  J Am Coll Cardiol       Date:  2015-05-19       Impact factor: 24.094

5.  Hematogenous pyogenic spinal infections and their surgical management.

Authors:  A G Hadjipavlou; J T Mader; J T Necessary; A J Muffoletto
Journal:  Spine (Phila Pa 1976)       Date:  2000-07-01       Impact factor: 3.468

6.  Primary pyogenic infection of the spine in intravenous drug users: a prospective observational study.

Authors:  Zhi Wang; Brian Lenehan; Eyal Itshayek; Michael Boyd; Marcel Dvorak; Charles Fisher; Brian Kwon; Scott Paquette; John Street
Journal:  Spine (Phila Pa 1976)       Date:  2012-04-15       Impact factor: 3.468

7.  Changing patient characteristics and the effect on mortality in endocarditis.

Authors:  Christopher H Cabell; James G Jollis; Gail E Peterson; G Ralph Corey; Deverick J Anderson; Daniel J Sexton; Christopher W Woods; L Barth Reller; Thomas Ryan; Vance G Fowler
Journal:  Arch Intern Med       Date:  2002-01-14

8.  Increasing deaths from opioid analgesics in the United States.

Authors:  Leonard J Paulozzi; Daniel S Budnitz; Yongli Xi
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-09       Impact factor: 2.890

9.  Diagnosis and management of primary pyogenic spinal infections in intravenous recreational drug users.

Authors:  Mateo Ziu; Bradley Dengler; Davin Cordell; Viktor Bartanusz
Journal:  Neurosurg Focus       Date:  2014-08       Impact factor: 4.047

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  136 in total

1.  Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.

Authors:  William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2018-11-26       Impact factor: 4.492

2.  Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.

Authors:  Asher J Schranz; Aaron Fleischauer; Vivian H Chu; Li-Tzy Wu; David L Rosen
Journal:  Ann Intern Med       Date:  2018-12-04       Impact factor: 25.391

3.  Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12.

Authors:  Douglas J Hsu; Ellen P McCarthy; Jennifer P Stevens; Kenneth J Mukamal
Journal:  Addiction       Date:  2017-03-16       Impact factor: 6.526

4.  Risk of reoperative valve surgery for endocarditis associated with drug use.

Authors:  Makoto Mori; Syed Usman Bin Mahmood; Asher J Schranz; Ibrahim Sultan; Andrea L Axtell; Nadeen Sarsour; William Hiesinger; Marko T Boskovski; Sameer Hirji; Tsuyoshi Kaneko; Joseph Woo; Paul Tang; Arminder S Jassar; Pavan Atluri; Bryan A Whitson; Thomas Gleason; Arnar Geirsson
Journal:  J Thorac Cardiovasc Surg       Date:  2019-07-10       Impact factor: 5.209

5.  Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.

Authors:  Michelle R Lofwall; Sharon L Walsh; Edward V Nunes; Genie L Bailey; Stacey C Sigmon; Kyle M Kampman; Michael Frost; Fredrik Tiberg; Margareta Linden; Behshad Sheldon; Sonia Oosman; Stefan Peterson; Michael Chen; Sonnie Kim
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

6.  Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.

Authors:  Kelsey C Priest; Travis I Lovejoy; Honora Englander; Sarah Shull; Dennis McCarty
Journal:  J Gen Intern Med       Date:  2020-04-14       Impact factor: 5.128

7.  Addiction Medicine Consultations Reduce Readmission Rates for Patients With Serious Infections From Opioid Use Disorder.

Authors:  Laura R Marks; Satish Munigala; David K Warren; Stephen Y Liang; Evan S Schwarz; Michael J Durkin
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

Review 8.  Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.

Authors:  Simeon Kimmel; Paxton Bach; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2020-05-27       Impact factor: 5.128

9.  Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study.

Authors:  Maria J D'Amico; Alexander Y Walley; Debbie M Cheng; Leah S Forman; Danny Regan; Alexandra Yurkovic; Jeffrey H Samet; Zoe M Weinstein
Journal:  J Subst Abuse Treat       Date:  2019-08-20

Review 10.  Opioids and Cancer Mortality.

Authors:  Jaya Amaram-Davila; Mellar Davis; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.